Hormone Care for Women: Reason, Baseline, Recheck (What 10,185 Records Showed, 2026) A November 2026 study in The Journal of Clinical Endocrinology & Metabolism looked at 10,185 US women newly starting one hormone treatment from 2016 to 2024. The evidence-based reason was documented for 17%, a baseline blood level for 16% and a recheck at 60 to 180 days for 10%. Health records can miss tests done elsewhere, and the study did not measure outcomes. The takeaway: ask for a reason, a baseline and a recheck. Education only; a licensed provider decides every treatment. What should a careful hormone treatment plan for women include? A careful plan includes a documented reason to start, a baseline blood level and a planned recheck. A November 2026 study of 10,185 US women found the reason documented for 17% and a recheck for 10%. HOO Longevity in the United States connects you with a licensed provider who builds all 3 steps into your plan. Sources: The Journal of Clinical Endocrinology & Metabolism, 2026: https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgag444/9027055 Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #hormonehealth #labwork #mensandwomenshealth #Shorts #HOOLongevityAcademy #JoinHOOHealth